Host cell transcription and translation machinery

The host cell transcription and translation machinery refers to the collective set of endogenous cellular components, including RNA polymerase II, transcription factors, ribosomes, and transfer RNAs, that are responsible for converting genetic information into functional proteins (Mendell et al., 2017, NEJM). In the context of gene replacement therapy for Spinal Muscular Atrophy (SMA), this machinery serves as the functional vehicle for the expression of the SMN1 transgene delivered by viral vectors such as onasemnogene abeparvovec (Zolgensma FDA Label). Once the AAV9 vector delivers the SMN1 DNA to the nucleus of target cells, primarily motor neurons, the host's transcriptional enzymes produce SMN1 mRNA, which is then translated by cytoplasmic ribosomes into functional Survival Motor Neuron (SMN) protein (Passini et al., 2010, J Clin Invest). This process is critical for addressing the underlying genetic cause of SMA, where mutations in the endogenous SMN1 gene lead to a deficiency of the SMN protein necessary for motor neuron survival (Lefebvre et al., 1995, Cell). While the machinery itself is not a drug target in the traditional sense, its efficiency and the stability of the resulting protein are the primary determinants of the therapy's clinical efficacy (Al-Zaidy et al., 2019, Pediatr Neurol). Consequently, the interaction between the delivered transgene and the host's protein synthesis apparatus is the fundamental mechanism by which gene therapies restore physiological function in genetic disorders.

Other names

Cellular expression machineryProtein synthesis machineryTranscription-translation apparatusEndogenous expression system

The host cell machinery facilitates the expression of the SMN1 transgene by transcribing the delivered DNA into mRNA and translating it into functional SMN protein, thereby bypassing the genetic defect in SMA patients.